The Oral Mucosa Immune Environment and Oral Transmission of HIV/SIV

Overview

Journal Immunol Rev

Specialties Allergy & Immunology
General Surgery

Date 2013 Jun 19

PMID 23772613

Citations 12

Authors

Lianna F Wood

Ann Chahroudi

Hui-Ling Chen

Heather B Jaspan

Donald L Sodora

Affiliations

Soon will be listed here.

Abstract

The global spread of human immunodeficiency virus (HIV) is dependent on the ability of this virus to efficiently cross from one host to the next by traversing a mucosal membrane. Unraveling how mucosal exposure of HIV results in systemic infection is critical for the development of effective therapeutic strategies. This review focuses on understanding the immune events associated with the oral route of transmission (via breastfeeding or sexual oral intercourse), which occurs across the oral and/or gastrointestinal mucosa. Studies in both humans and simian immunodeficiency virus (SIV) monkey models have identified viral changes and immune events associated with oral HIV/SIV exposure. This review covers our current knowledge of HIV oral transmission in both infants and adults, the use of SIV models in understanding early immune events, oral immune factors that modulate HIV/SIV susceptibility (including mucosal inflammation), and interventions that may impact oral HIV transmission rates. Understanding the factors that influence oral HIV transmission will provide the foundation for developing immune therapeutic and vaccine strategies that can protect both infants and adults from oral HIV transmission.

Citing Articles

Human seminal plasma stimulates the migration of CD11c+ mononuclear phagocytes to the apical side of the colonic epithelium without altering the junctional complexes in an human intestinal model.

Baratella M, Iannone V, Cavarelli M, Foglieni C, Vigano P, Moog C Front Immunol. 2023; 14:1133886.

PMID: 37033941 PMC: 10073423. DOI: 10.3389/fimmu.2023.1133886.

The Contribution of the Human Oral Microbiome to Oral Disease: A Review.

Morrison A, Sarkar S, Umar S, Lee S, Thomas S Microorganisms. 2023; 11(2).

PMID: 36838283 PMC: 9962706. DOI: 10.3390/microorganisms11020318.

Localization of infection in neonatal rhesus macaques after oral viral challenge.

Taylor R, McRaven M, Carias A, Anderson M, Matias E, Arainga M PLoS Pathog. 2021; 17(11):e1009855.

PMID: 34793582 PMC: 8639050. DOI: 10.1371/journal.ppat.1009855.

Pediatric HIV-1 Acquisition and Lifelong Consequences of Infant Infection.

Nelson C, Fouda G, Permar S Curr Immunol Rev. 2020; 15(1):131-138.

PMID: 33223981 PMC: 7678020. DOI: 10.2174/1573395514666180531074047.

Marginal Effects of Systemic CCR5 Blockade with Maraviroc on Oral Simian Immunodeficiency Virus Transmission to Infant Macaques.

Brocca-Cofano E, Xu C, Wetzel K, Cottrell M, Policicchio B, Raehtz K J Virol. 2018; 92(17).

PMID: 29925666 PMC: 6096825. DOI: 10.1128/JVI.00576-18.

References

Mayer K, Ayotte D, Groopman J, Stoddard A, Sarngadharan M, Gallo R . Association of human T lymphotropic virus type III antibodies with sexual and other behaviors in a cohort of homosexual men from Boston with and without generalized lymphadenopathy. Am J Med. 1986; 80(3):357-63. DOI: 10.1016/0002-9343(86)90706-0. View

Wang W, Owen S, Rudolph D, Cole A, Hong T, Waring A . Activity of alpha- and theta-defensins against primary isolates of HIV-1. J Immunol. 2004; 173(1):515-20. DOI: 10.4049/jimmunol.173.1.515. View

Hasselrot K, Bratt G, Duvefelt K, Hirbod T, Sandstrom E, Broliden K . HIV-1 exposed uninfected men who have sex with men have increased levels of salivary CC-chemokines associated with sexual behavior. AIDS. 2010; 24(10):1569-75. DOI: 10.1097/qad.0b013e32833ac646. View

Fultz P . Components of saliva inactivate human immunodeficiency virus. Lancet. 1986; 2(8517):1215. DOI: 10.1016/s0140-6736(86)92218-x. View

Wilks A, Perry J, Ehlinger E, Zahn R, White R, Gauduin M . High cell-free virus load and robust autologous humoral immune responses in breast milk of simian immunodeficiency virus-infected african green monkeys. J Virol. 2011; 85(18):9517-26. PMC: 3165740. DOI: 10.1128/JVI.00796-11. View

Kuhn L, Trabattoni D, Kankasa C, Sinkala M, Lissoni F, Ghosh M . Hiv-specific secretory IgA in breast milk of HIV-positive mothers is not associated with protection against HIV transmission among breast-fed infants. J Pediatr. 2006; 149(5):611-6. PMC: 2811256. DOI: 10.1016/j.jpeds.2006.06.017. View

Gaur A, Dominguez K, Kalish M, Rivera-Hernandez D, Donohoe M, Brooks J . Practice of feeding premasticated food to infants: a potential risk factor for HIV transmission. Pediatrics. 2009; 124(2):658-66. DOI: 10.1542/peds.2008-3614. View

Van Rompay K, Berardi C, Tarara R, Canfield D, Valverde C, Montefiori D . Passive immunization of newborn rhesus macaques prevents oral simian immunodeficiency virus infection. J Infect Dis. 1998; 177(5):1247-59. DOI: 10.1086/515270. View

Reynolds S, Risbud A, Shepherd M, Zenilman J, Brookmeyer R, Paranjape R . Recent herpes simplex virus type 2 infection and the risk of human immunodeficiency virus type 1 acquisition in India. J Infect Dis. 2003; 187(10):1513-21. DOI: 10.1086/368357. View

10.

Lohman-Payne B, Slyker J, Richardson B, Farquhar C, Majiwa M, Maleche-Obimbo E . Infants with late breast milk acquisition of HIV-1 generate interferon-gamma responses more rapidly than infants with early peripartum acquisition. Clin Exp Immunol. 2009; 156(3):511-7. PMC: 2691981. DOI: 10.1111/j.1365-2249.2009.03937.x. View

11.

Ma G, Greenwell-Wild T, Lei K, Jin W, Swisher J, Hardegen N . Secretory leukocyte protease inhibitor binds to annexin II, a cofactor for macrophage HIV-1 infection. J Exp Med. 2004; 200(10):1337-46. PMC: 2211913. DOI: 10.1084/jem.20041115. View

12.

Brenchley J, Price D, Schacker T, Asher T, Silvestri G, Rao S . Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006; 12(12):1365-71. DOI: 10.1038/nm1511. View

13.

Richardson B, Hughes J . Modeling breastmilk infectivity in HIV-1 infected mothers. Biometrics. 2003; 59(1):179-85. DOI: 10.1111/1541-0420.00021. View

14.

Hussain L, Lehner T . Comparative investigation of Langerhans' cells and potential receptors for HIV in oral, genitourinary and rectal epithelia. Immunology. 1995; 85(3):475-84. PMC: 1383923. View

15.

Moore J, Rahemtulla F, Kent L, Hall S, Ikizler M, Wright P . Oral epithelial cells are susceptible to cell-free and cell-associated HIV-1 infection in vitro. Virology. 2003; 313(2):343-53. DOI: 10.1016/s0042-6822(03)00283-6. View

16.

Winkelstein Jr W, Lyman D, Padian N, Grant R, Samuel M, Wiley J . Sexual practices and risk of infection by the human immunodeficiency virus. The San Francisco Men's Health Study. JAMA. 1987; 257(3):321-5. View

17.

Juarez Tomas M, Otero M, Ocana V, Nader-Macias M . Production of antimicrobial substances by lactic acid bacteria I: determination of hydrogen peroxide. Methods Mol Biol. 2004; 268:337-46. DOI: 10.1385/1-59259-766-1:337. View

18.

Moorthy A, Gupta A, Bhosale R, Tripathy S, Sastry J, Kulkarni S . Nevirapine resistance and breast-milk HIV transmission: effects of single and extended-dose nevirapine prophylaxis in subtype C HIV-infected infants. PLoS One. 2009; 4(1):e4096. PMC: 2606064. DOI: 10.1371/journal.pone.0004096. View

19.

Mofenson L . Antiretroviral drugs to prevent breastfeeding HIV transmission. Antivir Ther. 2010; 15(4):537-53. DOI: 10.3851/IMP1574. View

20.

Ou C, Ciesielski C, Myers G, Bandea C, Luo C, Korber B . Molecular epidemiology of HIV transmission in a dental practice. Science. 1992; 256(5060):1165-71. DOI: 10.1126/science.256.5060.1165. View